Pharmacology Quiz: Antiarrhythmic Classes

20 questions · exam conditions

0:00

Antiarrhythmic ClassesQuestion 1 of 20

A 68-year-old male with atrial fibrillation is managed with diltiazem for rate control. He is subsequently treated with clarithromycin for a community-acquired pneumonia. A few days later, he presents with dizziness and a heart rate of 35 bpm with evidence of high-grade AV block. What is the most likely pharmacological basis for this presentation?

Clarithromycin induced the hepatic metabolism of diltiazem, leading to a loss of rate control.

Diltiazem and clarithromycin have a synergistic effect in prolonging the QT interval, causing bradycardia.

A direct pharmacodynamic interaction at the AV node, where both drugs competitively block calcium channels.

Clarithromycin inhibited CYP3A4, leading to increased plasma concentrations of diltiazem.

← Back to quizzes

Pharmacology Quiz

Pharmacology Quiz: Antiarrhythmic Classes

Practice Antiarrhythmic Classes in Pharmacology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Antiarrhythmic Classes, giving you a quick way to practice the rules, question types, and explanations that matter most for Pharmacology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

Clarithromycin induced the hepatic metabolism of diltiazem, leading to a loss of rate control.
Diltiazem and clarithromycin have a synergistic effect in prolonging the QT interval, causing bradycardia.
A direct pharmacodynamic interaction at the AV node, where both drugs competitively block calcium channels.
Clarithromycin inhibited CYP3A4, leading to increased plasma concentrations of diltiazem. (correct answer)

Explanation: When you encounter a drug interaction question involving antibiotics and cardiovascular medications, focus on cytochrome P450 enzyme interactions—they're extremely common and clinically significant. This patient's severe bradycardia and AV block resulted from dramatically increased diltiazem levels. Clarithromycin is a potent CYP3A4 inhibitor, and diltiazem is primarily metabolized by this same enzyme. When clarithromycin blocks CYP3A4, diltiazem can't be metabolized normally, causing plasma concentrations to rise significantly. This leads to excessive calcium channel blockade at the AV node, resulting in the observed high-grade AV block and severe bradycardia. Answer A is backwards—clarithromycin inhibits rather than induces hepatic metabolism. If metabolism were increased, you'd expect reduced diltiazem effects, not the enhanced effects seen here. Answer B incorrectly describes the mechanism. While both drugs can affect cardiac conduction, this isn't about QT prolongation or synergistic pharmacodynamic effects. The issue is purely pharmacokinetic—too much diltiazem in the system. Answer C mischaracterizes both the interaction type and the mechanism. This isn't a direct pharmacodynamic interaction where both drugs compete for the same receptors. Clarithromycin doesn't directly block calcium channels; it's affecting diltiazem metabolism. Remember this pattern: macrolide antibiotics (clarithromycin, erythromycin) are notorious CYP3A4 inhibitors. When patients on calcium channel blockers, statins, or other CYP3A4 substrates receive these antibiotics, watch for signs of drug toxicity due to impaired metabolism.

Question 2

A pharmacologist is comparing the action potentials of a sinoatrial (SA) node pacemaker cell and a ventricular myocyte. A drug that selectively blocks the ion current responsible for Phase 0 of the ventricular myocyte action potential would belong to which antiarrhythmic class?

Class I (correct answer)
Class II
Class III
Class IV

Explanation: Phase 0 of the ventricular myocyte action potential is the rapid depolarization caused by a massive influx of sodium ions through fast voltage-gated sodium channels. Class I antiarrhythmics are defined by their ability to block these channels. The SA node pacemaker potential, in contrast, has a slower Phase 0 depolarization that is primarily mediated by calcium influx through L-type calcium channels. Therefore, a drug that selectively blocks the ventricular Phase 0 current is, by definition, a Class I agent.

Question 3

A patient in atrial fibrillation with a rapid ventricular response has a history of severe asthma and left ventricular dysfunction. The physician wishes to use an AV nodal blocking agent but must be cautious. Which statement correctly contrasts the properties of a Class II versus a Class IV agent in this context?

Class IV agents directly block calcium influx in the AV node, while Class II agents do so indirectly by reducing sympathetic input. (correct answer)
Class II agents are contraindicated due to negative inotropy, while Class IV agents are safe in asthma.
Both classes carry a risk of bronchospasm, but Class IV agents also have significant negative inotropic effects.
Class II agents are preferred as they lack the negative inotropic effects seen with Class IV agents.

Explanation: When approaching AV nodal blocking agents in patients with multiple comorbidities, you need to understand how Class II (beta-blockers) and Class IV (calcium channel blockers) achieve their effects through different mechanisms. Class IV agents like verapamil and diltiazem work by directly blocking L-type calcium channels in the AV node, which are essential for conduction through this tissue. This direct calcium channel blockade slows AV conduction effectively. Class II agents (beta-blockers) achieve AV nodal blockade indirectly by antagonizing beta-1 receptors, thereby reducing sympathetic stimulation of the AV node. While sympathetic input does influence calcium influx, beta-blockers don't directly block the calcium channels themselves. Choice A correctly captures this mechanistic difference - Class IV agents directly block calcium influx, while Class II agents reduce it indirectly through sympathetic inhibition. Choice B is backwards regarding safety profiles. Beta-blockers are contraindicated in severe asthma due to beta-2 receptor blockade causing bronchospasm, and both drug classes have negative inotropic effects that concern us with left ventricular dysfunction. Choice C incorrectly states that calcium channel blockers cause bronchospasm - they don't significantly affect respiratory function since they don't block beta-2 receptors. Choice D reverses the negative inotropic comparison. Both classes have negative inotropic effects, but non-dihydropyridine calcium channel blockers often have more pronounced effects on myocardial contractility. Remember: always consider both the mechanism of action and the receptor selectivity when choosing between drug classes in patients with multiple contraindications.

Question 4

The Cardiac Arrhythmia Suppression Trial (CAST) demonstrated increased mortality in post-myocardial infarction patients treated with flecainide or encainide for asymptomatic ventricular ectopy. What is the most likely electrophysiological reason for this finding?

Marked slowing of ventricular conduction created a substrate for lethal re-entrant arrhythmias. (correct answer)
Profound AV nodal blockade resulted in complete heart block and asystole.
Excessive QT prolongation from potassium channel blockade led to Torsades de Pointes.
Negative inotropic effects precipitated cardiogenic shock in already damaged hearts.

Explanation: When you encounter questions about antiarrhythmic drug toxicity, focus on how each drug class affects cardiac conduction and the potential consequences in diseased hearts. The CAST trial revealed a paradoxical increase in mortality with Class IC antiarrhythmics (flecainide and encainide) in post-MI patients. These drugs are potent sodium channel blockers that significantly slow conduction velocity throughout the ventricles. In hearts already damaged by myocardial infarction, this marked conduction slowing creates ideal conditions for re-entrant circuits. The slow conduction allows wavefronts of electrical activity to circle back and re-excite tissue that has recovered from its refractory period, establishing dangerous ventricular tachycardia or fibrillation. Answer A correctly identifies this mechanism. Answer B is incorrect because Class IC drugs primarily affect ventricular sodium channels, not AV nodal conduction, and complete heart block wasn't the predominant cause of death in CAST. Answer C describes Class III antiarrhythmics (like sotalol or amiodarone) that block potassium channels and prolong the QT interval, not the mechanism of flecainide or encainide toxicity. Answer D, while Class IC drugs do have some negative inotropic effects, misses the primary electrophysiological mechanism - the increased mortality was specifically due to proarrhythmic effects, not heart failure. Remember: Class IC antiarrhythmics are contraindicated in structural heart disease precisely because their powerful sodium channel blocking effects can convert benign arrhythmias into lethal ones by creating the perfect substrate for re-entry in damaged myocardium.

Question 5

A patient is experiencing ventricular tachycardia (VT) that is exacerbated by exercise. An antiarrhythmic agent is administered that demonstrates increased efficacy as the heart rate increases during a stress test. This property of 'use-dependence' is most prominent in drugs that block which type of channel?

Potassium channels that are blocked more effectively at slower heart rates.
Sodium channels with rapid binding and unbinding kinetics, favoring blockade during tachycardia. (correct answer)
L-type calcium channels that are primarily located in nodal tissue and show rate-dependent blockade.
Beta-adrenergic receptors whose blockade is independent of heart rate.

Explanation: Use-dependence refers to the phenomenon where a drug's effect increases with the frequency of channel activation. Class I antiarrhythmics, particularly subclasses Ib (e.g., lidocaine) and Ic (e.g., flecainide), exhibit this property. These drugs bind more effectively to sodium channels that are in the open or inactivated state, states that are more prevalent during rapid heart rates. Lidocaine (Class Ib) has rapid kinetics, allowing it to block the numerous depolarizations during tachycardia but dissociate during diastole, making it particularly effective for tachyarrhythmias. Some Class III agents show the opposite ('reverse use-dependence').

Question 6

Sotalol is an antiarrhythmic agent that uniquely combines two distinct class mechanisms. Its action is best described as:

Class Ia sodium channel blockade and Class III potassium channel blockade.
Class Ic sodium channel blockade and Class II beta-adrenergic blockade.
Class II beta-adrenergic blockade and Class III potassium channel blockade. (correct answer)
Class III potassium channel blockade and Class IV calcium channel blockade.

Explanation: Sotalol is a non-selective beta-blocker (Class II activity) that also blocks the delayed rectifier potassium current (IKr), thus prolonging repolarization and the action potential duration (Class III activity). This dual mechanism makes it effective for both atrial and ventricular arrhythmias. The beta-blockade helps control rate and suppress triggers, while the potassium channel blockade helps prevent re-entry. This combination of Class II and Class III properties is unique to sotalol among commonly used antiarrhythmics.

Question 7

A patient with atrial fibrillation is treated with an antiarrhythmic drug. Subsequent ECG analysis reveals a significant widening of the QRS complex, but the QT interval remains largely unchanged. This specific combination of ECG effects is most characteristic of which class of antiarrhythmic agents?

Class Ia, which moderately blocks sodium channels and prolongs repolarization.
Class Ib, which weakly blocks sodium channels and shortens repolarization.
Class Ic, which strongly blocks sodium channels with minimal effect on repolarization. (correct answer)
Class III, which primarily blocks potassium channels to prolong repolarization.

Explanation: Widening of the QRS complex is caused by slowing of ventricular conduction, a result of blocking Phase 0 (sodium influx). The QT interval represents the total duration of ventricular depolarization and repolarization. Class Ic agents (e.g., flecainide, propafenone) are potent sodium channel blockers, causing marked slowing of conduction and significant QRS widening. However, they have minimal effect on potassium channels or repolarization, so the action potential duration and thus the QT interval are not significantly affected. Class Ia prolongs both QRS and QT. Class Ib has minimal effect on QRS and may shorten QT. Class III primarily prolongs the QT interval with little effect on the QRS complex.

Question 8

A patient is being treated with an antiarrhythmic agent that causes significant prolongation of the effective refractory period (ERP) in atrial and ventricular tissues. This effect is primarily achieved by delaying Phase 3 repolarization. This mechanism increases the risk of which specific proarrhythmia?

AV nodal re-entrant tachycardia
Sinus bradycardia and junctional escape rhythms
Fascicular ventricular tachycardia
Torsades de Pointes (correct answer)

Explanation: The mechanism described—prolonging the ERP by delaying Phase 3 repolarization—is the hallmark of Class III antiarrhythmics (and to a lesser extent, Class Ia). This action prolongs the QT interval on the ECG. Excessive QT prolongation can lead to early afterdepolarizations (EADs), which can trigger a polymorphic ventricular tachycardia known as Torsades de Pointes (TdP). This is the most feared proarrhythmic effect of this drug class.

Question 9

A patient is started on dofetilide for persistent atrial fibrillation. The clinical team is advised that the risk of proarrhythmia, specifically Torsades de Pointes (TdP), is paradoxically highest when the patient's heart rate is low. This phenomenon is best described as:

Use-dependence, where the drug binds preferentially to activated channels.
Reverse use-dependence, where the drug's blocking effect is more potent at slower heart rates. (correct answer)
State-independent blockade, where the drug binds equally to all channel conformations.
Tachyphylaxis, where the drug's effect diminishes rapidly with repeated administration.

Explanation: Reverse use-dependence is a characteristic of certain Class III antiarrhythmics, such as dofetilide and sotalol. These drugs block the IKr potassium channel more effectively at slower heart rates. This leads to more significant QT prolongation and an increased risk of early afterdepolarizations (EADs) and Torsades de Pointes during periods of bradycardia. Use-dependence is the opposite phenomenon, seen with Class I and IV agents. Tachyphylaxis is a rapid decrease in response to a drug.

Question 10

A patient presents with an atrioventricular nodal reentrant tachycardia (AVNRT). The therapeutic goal is to terminate the arrhythmia by slowing conduction and increasing refractoriness specifically within the AV node. Which agent's primary mechanism of action is best suited for this purpose?

Lidocaine
Flecainide
Diltiazem (correct answer)
Ibutilide

Explanation: Diltiazem is a Class IV (non-dihydropyridine calcium channel blocker) antiarrhythmic. Its primary site of action is the sinoatrial (SA) and atrioventricular (AV) nodes, where the action potential upstroke is dependent on calcium influx. By blocking these L-type calcium channels, diltiazem slows AV nodal conduction and increases its refractory period, making it highly effective for terminating AVNRT. Lidocaine (Class Ib) acts primarily on ventricular tissue. Flecainide (Class Ic) acts on His-Purkinje fibers and atrial/ventricular muscle. Ibutilide (Class III) acts broadly by prolonging repolarization.

Question 11

An electrophysiologist wants to pharmacologically manage a patient's ventricular arrhythmia by primarily prolonging the effective refractory period (ERP) of ventricular myocytes, while causing the least possible change in cardiac conduction velocity. Which class of drugs best fits this specific electrophysiological profile?

Class Ia, which prolongs ERP but also significantly slows conduction.
Class Ic, which markedly slows conduction but has minimal effect on ERP.
Class III, which primarily prolongs ERP by delaying repolarization. (correct answer)
Class IV, which has minimal direct effects on ventricular myocyte ERP or conduction.

Explanation: The question asks for a drug that maximizes the increase in ERP while minimizing the effect on conduction velocity. This profile perfectly describes Class III antiarrhythmics (e.g., amiodarone, sotalol, dofetilide). Their primary mechanism is blocking potassium channels to delay repolarization, which directly prolongs the APD and ERP. They have little to no effect on sodium channels, so conduction velocity (reflected by the QRS duration) is largely unaffected. The other classes do not fit this specific profile as described in the distractors.

Question 12

A patient with life-threatening ventricular arrhythmias refractory to other treatments is administered a drug known for its complex pharmacology, exhibiting properties of all four Vaughan Williams classes. This agent prolongs the QT interval, slows heart rate, widens the QRS complex, and has vasodilatory effects. Which medication was most likely given?

Sotalol
Amiodarone (correct answer)
Propafenone
Procainamide

Explanation: Amiodarone is a unique antiarrhythmic agent renowned for its broad spectrum of action, encompassing properties of all four classes. It blocks sodium channels (Class I), has non-competitive beta-blocking effects (Class II), potently blocks potassium channels to prolong the action potential (Class III), and weakly blocks calcium channels (Class IV). Sotalol has Class II and III properties. Propafenone has Class Ic properties with weak beta-blockade. Procainamide is a Class Ia agent.

Question 13

AV nodal re-entrant tachycardia
Sinus bradycardia and junctional escape rhythms
Fascicular ventricular tachycardia
Torsades de Pointes (correct answer)

Question 14

A patient with Wolff-Parkinson-White (WPW) syndrome develops atrial fibrillation. The rapid atrial impulses can conduct to the ventricles via both the normal AV node and the fast accessory pathway. Administration of which of the following drugs would be most dangerous in this situation?

Procainamide
Ibutilide
Amiodarone
Verapamil (correct answer)

Explanation: When treating arrhythmias in WPW syndrome, you must understand how different drugs affect the accessory pathway versus the AV node. In WPW with atrial fibrillation, the dangerous scenario occurs when rapid atrial impulses bypass the AV node's natural "braking" function and conduct directly to the ventricles through the fast accessory pathway, potentially causing ventricular fibrillation. Verapamil (D) is most dangerous because it's an AV nodal blocker that will slow conduction through the normal AV node while having no effect on the accessory pathway. This creates a preferential pathway for rapid atrial impulses to reach the ventricles via the accessory route, dramatically increasing ventricular rate and risk of ventricular fibrillation. Procainamide (A) is actually beneficial here because it blocks sodium channels in the accessory pathway, slowing conduction through this dangerous route. Ibutilide (B) blocks potassium channels and can terminate atrial fibrillation while also affecting the accessory pathway. Amiodarone (C) has multiple mechanisms including blocking the accessory pathway and is considered safe in WPW. The key principle: in WPW with atrial fibrillation, avoid drugs that selectively block the AV node (like verapamil, diltiazem, or digoxin) because they can paradoxically worsen the situation by forcing more conduction through the accessory pathway. Study tip: Remember "WPW + A-fib = avoid AV blockers." Focus on drugs that affect the accessory pathway itself (sodium channel blockers like procainamide) rather than those that only slow the normal conduction system.

Question 15

Use-dependence, where the drug binds preferentially to activated channels.
Reverse use-dependence, where the drug's blocking effect is more potent at slower heart rates. (correct answer)
State-independent blockade, where the drug binds equally to all channel conformations.
Tachyphylaxis, where the drug's effect diminishes rapidly with repeated administration.

Question 16

Lidocaine
Flecainide
Diltiazem (correct answer)
Ibutilide

Question 17

A patient with ventricular tachycardia secondary to an acute myocardial infarction is treated with an antiarrhythmic. The chosen drug is particularly effective in this setting because it preferentially binds to sodium channels in the inactivated state, a state that is more common in the depolarized, ischemic myocardial cells. Which drug best fits this mechanistic description?

Propafenone
Quinidine
Lidocaine (correct answer)
Sotalol

Explanation: Class Ib agents, such as lidocaine, exhibit a high affinity for sodium channels in the open and, particularly, the inactivated states. Ischemic tissue is partially depolarized, which increases the proportion of sodium channels in the inactivated state. This makes lidocaine more effective at blocking channels in damaged tissue compared to healthy tissue, a property known as tissue-selectivity. Class Ia (quinidine) and Ic (propafenone) agents bind more to the open state. Sotalol is primarily a Class III agent acting on potassium channels.

Question 18

Class IV agents directly block calcium influx in the AV node, while Class II agents do so indirectly by reducing sympathetic input. (correct answer)
Class II agents are contraindicated due to negative inotropy, while Class IV agents are safe in asthma.
Both classes carry a risk of bronchospasm, but Class IV agents also have significant negative inotropic effects.
Class II agents are preferred as they lack the negative inotropic effects seen with Class IV agents.

Question 19

While most Class I antiarrhythmics either prolong or have no effect on the action potential duration (APD), one subclass characteristically causes a slight shortening of the APD in normal ventricular tissue. This effect is a defining feature of which subclass?

Class Ia (e.g., Quinidine)
Class Ib (e.g., Lidocaine) (correct answer)
Class Ic (e.g., Flecainide)
This effect is not observed with any Class I agent.

Explanation: Class Ib agents, such as lidocaine and mexiletine, are unique among the sodium channel blockers in that they shorten the action potential duration and, consequently, the QT interval. The exact mechanism is complex but is thought to involve blockade of a small, persistent 'late' sodium current that flows during the plateau phase. By blocking this current, they hasten repolarization. Class Ia agents prolong APD, and Class Ic agents have little to no effect on APD.

Question 20

Clarithromycin induced the hepatic metabolism of diltiazem, leading to a loss of rate control.
Diltiazem and clarithromycin have a synergistic effect in prolonging the QT interval, causing bradycardia.
A direct pharmacodynamic interaction at the AV node, where both drugs competitively block calcium channels.
Clarithromycin inhibited CYP3A4, leading to increased plasma concentrations of diltiazem. (correct answer)